
Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Piracetam is a nootropic compound that enhances cognitive function by modulating AMPA receptors and increasing acetylcholine receptor density in the brain. This racetam works primarily by improving neuronal membrane fluidity and enhancing neurotransmitter activity.

Reported Benefits (Provisional)
Origin & History

Piracetam is a synthetic nootropic compound first developed in the 1960s. It is produced through chemical synthesis and is known for its cognitive-enhancing properties.
Research Narrative (Provisional)
Numerous clinical trials have explored Piracetam's effects on cognitive function, particularly in older adults and those with cognitive impairments. Evidence supports its role in enhancing memory and learning.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Does not provide traditional nutrients but acts as a cognitive enhancer. - Modulates neurotransmitter activity, particularly acetylcholine. - Influences brain metabolism and energy utilization.
Reported Mechanism (Provisional)
Piracetam modulates AMPA receptors and increases acetylcholine receptor density, particularly affecting muscarinic and nicotinic receptors. The compound enhances neuronal membrane fluidity by altering phospholipid composition and increases cerebral blood flow through vasodilation. Piracetam also influences dopamine and serotonin neurotransmission while protecting neurons from oxidative stress.
Clinical Narrative (Provisional)
Human studies on piracetam show mixed results, with some randomized controlled trials demonstrating cognitive improvements in elderly participants with cognitive decline. A meta-analysis of 19 studies found modest benefits for memory and learning in doses ranging from 1.2-4.8g daily. However, evidence for cognitive enhancement in healthy young adults remains limited, with several placebo-controlled trials showing no significant effects. Most research has focused on populations with existing cognitive impairment rather than cognitive enhancement in healthy individuals.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.







